Skip to main content
. 2016 Aug 3;82(5):1291–1302. doi: 10.1111/bcp.13059

Table 2.

Comparative risk of hypoglycaemia of any severity. Results are the odds‐ratios (ORs) with 95% credibility intervals (CI). ORs less than 1 favour the column defining treatment in terms of lower risk of hypoglycaemia. Results are statistically significant where the CIs do not cross 1.

Gliclazide
0.40 (0.13, 1.27) Glimepiride
0.21 (0.03, 1.48) 0.51 (0.09, 2.83) Glibenclamide
0.22 (0.05, 0.96) 0.54 (0.18, 1.64) 1.04 (0.18, 6.85) Glipizide